Sign of Progress at the FDA? NBCC has long pushed for drug approvals based on clinically-significant outcomes: meaningful improvements in […]
Join us at the Park Hyatt Hotel in Washington, DC, from May 3-5 for a weekend of exciting programming, followed by Lobby Day on Capitol Hill on May 6.
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
Sign of Progress at the FDA? NBCC has long pushed for drug approvals based on clinically-significant outcomes: meaningful improvements in […]
2021 Legislative and Public Policy Priorities This month, The NBCC Board of Directors met and approved a set of legislative […]
COVID-19 Vaccination and Cancer Are breast cancer patients considered high-risk and given priority for the COVID vaccines? It depends on […]
Early-stage hormone-receptor positive, HER2 negative (HR+/HER2-) breast cancer is the most commonly diagnosed type of breast cancer. While the majority […]
NBCC Champions Democracy All 50 states certified the ballots cast for President in the 2020 election. On January 6th as […]
The Honorable Nancy Pelosi U.S. House of Representatives Washington, DC 20515 I write on behalf of the National Breast Cancer […]
